| |||||||||
ISMP Canada NewsJanuary 11, 2018: Health Canada: OFEV (nintedanib): Risk of Drug–Induced Liver Injury & the Need for Regular Monitoring of Liver Function |
|||||||||
Copyright © 2000-2016 Institute for Safe Medication Practices Canada (ISMP Canada). All Rights Reserved. |